|
GB201107197D0
|
|
Compounds
|
|
GB201107204D0
|
|
Compounds
|
|
GB201107176D0
|
|
Pyrrolnitrin derivatives
|
|
GB201002861D0
|
|
Compositions
|
|
US2010093017A1
|
|
Metabolically Competent Cell Lines
|
|
GB0818416D0
|
|
Metabolically competent cell lines
|
|
GB0809805D0
|
|
Knock-in transgenic non-human animal models
|
|
GB0710403D0
|
|
Knock-in Tracnsgenic non-human animal models
|
|
GB0609215D0
|
|
p53 dependent and independent gene expression
|
|
US2006292694A1
|
|
Reporter hepatocytes and other cells for drug screening and toxicity testing
|
|
US2006292695A1
|
|
Methods and kits for drug screening and toxicity testing using promoter-reporter cells derived from embryonic stem cells
|
|
GB0427172D0
|
|
Transgenic animals for assessing drug metabolism and toxicity
|
|
GB0415963D0
|
|
Detection of cellular stress
|
|
GB0322196D0
|
|
Excretable reporter systems
|
|
EP1534260A2
|
|
Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation
|
|
GB0308150D0
|
|
Method of determining xenograft responses
|
